Eli Lilly & Co. News, Eli Lilly & Co. Quote, LLY Quote

Eli Lilly & Co. (NY:LLY) Delayed: 1098.57 -13.43 (1.21%)

Prev. Close

$1112.00

Today 6M 1Y 5Y

Open

$1120.49

52 Wk High

$88.16

52 Wk Low

$67.88

Day High

$1122.33

Day Low

$1088.66

P/E

254.30

EPS

$4.32

Volume

4,470,563

Friends, Peers and Foes (?): NVO, HIMS, PFE, ABBV, MRK (more...)

ALERTS | RSS

Jun 18, 2026 05:47 AM Oral Wegovy reaches 33% of total prescriptions by May
Jun 16, 2026 04:26 PM Form 4 ELI LILLY & Co For: Jun 15 Filed by: Sulzberger Gabrielle
Jun 16, 2026 04:25 PM Form 4 ELI LILLY & Co For: Jun 15 Filed by: LUCIANO JUAN R
Jun 16, 2026 04:14 PM Form 4 ELI LILLY & Co For: Jun 15 Filed by: Fyrwald J Erik
Jun 16, 2026 04:13 PM Form 4 ELI LILLY & Co For: Jun 15 Filed by: Alvarez Ralph
Jun 15, 2026 04:08 PM Raymond James Starts Aktis Oncology (AKTS) at Strong Buy (correction)
Jun 15, 2026 10:11 AM BMO Capital on Eli Lilly (LLY): 'Early Data for AJ1-11095 Impress at EHA'
Jun 14, 2026 08:05 AM Lilly's Jaypirca reduces disease progression risk by 45% in CLL study
Jun 14, 2026 03:15 AM Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Jun 12, 2026 02:42 PM Leerink highlights drug demand rebound after Memorial Day

Entities mentioned with LLY

View All Entities